首頁 > 市場調查報告書 > 醫療設備

e保健醫院 IT

市場調查報告書

商品編碼

1542475

全球臨床決策支援系統市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Clinical Decision Support System Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球臨床決策支援系統市場需求預計將從2023年的58.3億美元達到2032年近154.9億美元的市場規模，2024-2032年研究期間的複合年成長率為11.46%。

臨床決策支援系統（CDSS）是一種醫療保健資訊科技工具，旨在協助醫療保健專業人員完成臨床決策任務。 CDSS 整合了來自電子健康記錄 (EHR)、醫學知識庫和臨床指南的患者資料，以在照護端提供基於證據的建議和警報。它分析患者的特定訊息，例如實驗室結果、病史和當前用藥，以支持診斷和治療決策。 CDSS 旨在透過減少醫療錯誤、最佳化資源利用率以及促進遵守最佳實踐和臨床方案來改善臨床結果、病患安全和工作流程效率。

市場動態

電子健康記錄和互通性標準的日益普及鼓勵將臨床決策支援系統整合到醫療保健工作流程中，從而促進跨護理環境無縫存取患者資料和決策支援工具。 CDSS 解決方案利用人工智慧 (AI)、機器學習 (ML) 和自然語言處理 (NLP) 演算法來分析大量資料集、預測臨床結果並根據患者特定特徵提出個人化治療建議。監管措施和醫療改革促進 CDSS 的使用，以改善護理協調、降低醫療成本並減少醫療差錯。 CDSS 與遠距醫療平台和行動醫療應用程式的整合支援遠端患者監控、虛擬諮詢和個人化健康管理，從而增強患者參與度和護理連續性。

此外，臨床資訊學、巨量資料分析和雲端運算的進步推動了臨床決策支援系統功能的創新，實現了即時決策支援、臨床路徑最佳化和人口健康管理。市場機會包括擴大 CDSS 在慢性病管理、精準醫療計劃和臨床試驗中的應用，其中預測分析和決策支援工具可以簡化複雜的決策過程並改善治療結果。然而，不同醫療保健 IT 系統之間的互通性障礙、資料隱私問題以及醫療保健提供者之間對變革的抵制等挑戰可能會阻礙臨床決策支援系統市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球臨床決策支援系統市場的各個細分市場進行了包容性評估。臨床決策支援系統產業的成長和趨勢為本研究提供了整體方法。

市場區隔

臨床決策支援系統市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

獨立CDSS
整合 CPOE 與 CDSS
與 CDSS 整合 EHR
與 CPOE 和 EHR 整合的 CDSS

按申請

藥物間相互作用
藥物過敏警報
臨床提醒
臨床指引
藥物劑量支持
其他

按交付方式

網路為基礎的系統
基於雲端的系統
本地系統

按組件

硬體
軟體
服務

區域分析

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲臨床決策支援系統市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。臨床決策支援系統市場的主要參與者包括 McKesson Corporation、Oracle (Cerner Corporation)、Siemens Healthineers GmbH、Allscripts Healthcare LLC、Athenahealth Inc.、NextGen Healthcare Inc.、Koninklijke Philips NV IBM、Agfa-Gevaert Group、Wolters Kluwer NV本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按產品分類的市場吸引力分析
- 市場吸引力分析：依應用分類
- 按交付模式分類的市場吸引力分析
- 按組件分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球臨床決策支援系統市場分析：按產品

概述（按產品）
按產品分類的歷史和預測資料分析
獨立CDSS
整合 CPOE 與 CDSS
與 CDSS 整合 EHR
與 CPOE 和 EHR 整合的 CDSS

第 6 章：全球臨床決策支援系統市場分析：按應用分類

概述：按應用
歷史和預測數據分析：按應用
藥物間相互作用
藥物過敏警報
臨床提醒
臨床指引
藥物劑量支持
其他

第 7 章：全球臨床決策支援系統市場分析：按交付模式

按交付模式概述
按交付模式進行歷史和預測資料分析
網路為基礎的系統
基於雲端的系統
本地系統

第 8 章：全球臨床決策支援系統市場分析：按組成部分

按組件概述
按組成部分的歷史和預測資料分析
硬體
軟體
服務

第 9 章：全球臨床決策支援系統市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：臨床決策支援系統公司的競爭格局

臨床決策支援系統市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
McKesson Corporation

公司概況
公司收入
產品
最新動態

Oracle (Cerner Corporation)

公司概況
公司收入
產品
最新動態

Siemens Healthineers GmbH

公司概況
公司收入
產品
最新動態

Allscripts Healthcare LLC

公司概況
公司收入
產品
最新動態

Athenahealth Inc.

公司概況
公司收入
產品
最新動態

NextGen Healthcare Inc.

公司概況
公司收入
產品
最新動態

Koninklijke Philips NV IBM

公司概況
公司收入
產品
最新動態

Agfa-Gevaert Group

公司概況
公司收入
產品
最新動態

Wolters Kluwer NV

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11212597

The global demand for Clinical Decision Support System Market is presumed to reach the market size of nearly USD 15.49 Billion by 2032 from USD 5.83 Billion in 2023 with a CAGR of 11.46% under the study period 2024-2032.

A clinical decision support system (CDSS) is a healthcare information technology tool designed to assist healthcare professionals in clinical decision-making tasks. CDSS integrates patient data from electronic health records (EHRs), medical knowledge bases, and clinical guidelines to provide evidence-based recommendations and alerts at the point of care. It analyzes patient-specific information, such as lab results, medical history, and current medications, to support diagnostic and treatment decisions. CDSS aims to improve clinical outcomes, patient safety, and workflow efficiency by reducing medical errors, optimizing resource utilization, and promoting adherence to best practices and clinical protocols.

MARKET DYNAMICS

The increasing adoption of electronic health records and interoperability standards encourages the integration of clinical decision-support systems into healthcare workflows, facilitating seamless access to patient data and decision-support tools across care settings. CDSS solutions leverage artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) algorithms to analyze vast datasets, predict clinical outcomes, and personalize treatment recommendations based on patient-specific characteristics. Regulatory initiatives and healthcare reforms promote the use of CDSS to improve care coordination, reduce healthcare costs, and mitigate medical errors. Integration of CDSS with telehealth platforms and mobile health applications supports remote patient monitoring, virtual consultations, and personalized health management, enhancing patient engagement and continuity of care.

Moreover, advancements in clinical informatics, big data analytics, and cloud computing drive innovation in clinical decision support system capabilities, enabling real-time decision support, clinical pathway optimization, and population health management. Opportunities in the market include expanding CDSS applications in chronic disease management, precision medicine initiatives, and clinical trials, where predictive analytics and decision support tools streamline complex decision-making processes and improve treatment outcomes. However, challenges such as interoperability barriers between disparate healthcare IT systems, data privacy concerns, and resistance to change among healthcare providers may hinder the clinical decision support system market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Clinical Decision Support System. The growth and trends of Clinical Decision Support System industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Clinical Decision Support System market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Standalone CDSS
Integrated CPOE with CDSS
Integrated EHR with CDSS
Integrated CDSS with CPOE & EHR

By Application

Drug-Drug Interactions
Drug Allergy Alerts
Clinical Reminders
Clinical Guidelines
Drug Dosing Support
Others

By Delivery Mode

Web-Based Systems
Cloud-Based Systems
On -Premise Systems

By Component

Hardware
Software
Services

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Decision Support System market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Decision Support System market include McKesson Corporation, Oracle (Cerner Corporation), Siemens Healthineers GmbH, Allscripts Healthcare LLC, Athenahealth Inc., NextGen Healthcare Inc., Koninklijke Philips N.V. IBM, Agfa-Gevaert Group, Wolters Kluwer N.V. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CLINICAL DECISION SUPPORT SYSTEM - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Delivery Mode
- 3.7.4 Market Attractiveness Analysis By Component
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Standalone CDSS Historic and Forecast Sales By Regions
5.4. Integrated CPOE with CDSS Historic and Forecast Sales By Regions
5.5. Integrated EHR with CDSS Historic and Forecast Sales By Regions
5.6. Integrated CDSS with CPOE & EHR Historic and Forecast Sales By Regions

6. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Drug-Drug Interactions Historic and Forecast Sales By Regions
6.4. Drug Allergy Alerts Historic and Forecast Sales By Regions
6.5. Clinical Reminders Historic and Forecast Sales By Regions
6.6. Clinical Guidelines Historic and Forecast Sales By Regions
6.7. Drug Dosing Support Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY DELIVERY MODE

7.1. Overview By Delivery Mode
7.2. Historical and Forecast Data Analysis By Delivery Mode
7.3. Web-Based Systems Historic and Forecast Sales By Regions
7.4. Cloud-Based Systems Historic and Forecast Sales By Regions
7.5. On -Premise Systems Historic and Forecast Sales By Regions

8. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY COMPONENT

8.1. Overview By Component
8.2. Historical and Forecast Data Analysis By Component
8.3. Hardware Historic and Forecast Sales By Regions
8.4. Software Historic and Forecast Sales By Regions
8.5. Services Historic and Forecast Sales By Regions

9. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CLINICAL DECISION SUPPORT SYSTEM COMPANIES

10.1. Clinical Decision Support System Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CLINICAL DECISION SUPPORT SYSTEM INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. McKesson Corporation
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Oracle (Cerner Corporation)
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Siemens Healthineers GmbH
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Allscripts Healthcare LLC
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Athenahealth Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. NextGen Healthcare Inc.
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Koninklijke Philips N.V. IBM
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Agfa-Gevaert Group
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Wolters Kluwer N.V
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments